Complex regional pain syndrome. Complex regional pain syndrome I (CRPS I)
Conditions
Interventions
Intervention 1: Intervention group: High-power laser with K-laser brand with a power of 5 watts with a dose of 20 joules per square centimeter and a cross-sectional area of 1 cm in 3 phases in the ent
Sponsors
The University of Tarbiat modares
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Diagnosis by a neurologist or orthopedist of a complex regional pain syndrome in the participant's hand Men and women with type 1 complex regional pain syndrome based on the Budapest standard The patient's hand is involved Having constant pain that is not commensurate with the accident that caused it There is edema or swelling in the hand relative to the healthy side
Exclusion criteria
Exclusion criteria: Pregnancy Infection Radiotherapy in the last 6 months cancer Patients with stroke People's unwillingness to continue treatment for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level changes. Timepoint: Measurement of pain at the beginning of the study (before the intervention) and at the end of treatment sessions (seven sessions and three sessions per week for a total of fourteen days after the intervention). Method of measurement: Visual analogue scale.;Hand function changes. Timepoint: Measurement of changes in hand function at the beginning of the study (before the intervention) and at the end of treatment sessions (seven sessions and three sessions per week for a total of fourteen days after the intervention). Method of measurement: Fugl-Meyer Evaluation Scale.;Hand swelling changes. Timepoint: Measurement of changes in hand swelling at the beginning of the study (before the intervention) and at the end of treatment sessions (seven sessions and three sessions per week for a total of fourteen days after the intervention). Method of measurement: Measurement by Figure of eight method.;Range of motion. Timepoint: Measurement of range of motion at the beginning of the study (before the intervention) and at the end of the treatment sessions (seven sessions and three sessions per week for a total of fourteen days after the intervention). Method of measurement: Goniameter.;The amount of muscle activity. Timepoint: Measurement of muscle activity at the beginning of the study (before the intervention) and at the end of the treatment sessions (seven sessions and three sessions per week for a total of fourteen days after the intervention). Method of measurement: Electromyography device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhan Khorramdel
The University of Tarbiat Modares
Outcome results
None listed